Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia

Toby N. Weingarten, Vikram R. Podduturu, W. Michael Hooten, Jeffrey M. Thompson, Connie A. Luedtke, Terry H. Oh

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

OBJECTIVES: This study examined the relationship between the severity of fibromyalgia symptoms and current tobacco use in patients evaluated at a specialized fibromyalgia treatment program. METHODS: Demographic and clinical data from 984 consecutive patients evaluated at the Mayo Clinic Fibromyalgia Treatment Program including the Fibromyalgia Impact Questionnaire (FIQ) were prospectively collected and stored in an electronic medical record and an electronic database. Univariate analyses were performed comparing tobacco users and nonusers. A post-hoc analysis of covariance was conducted for tobacco use, using group differences of confounding clinical and demographic variables. A P value ? 0.05 was accepted as the level of significance. RESULTS: One hundred and forty-five patients were identified as tobacco users (14.7%). Tobacco use was associated with greater pain intensity as measured by pain scales and the pain component of the FIQ. Tobacco users had a greater FIQ composite score 70.0(15.1) versus 61.8(16.8), P<0.001. By univariate analysis, tobacco users had higher scores on all the FIQ components and fewer good days and more days of work missed per week. Tobacco use was associated with several confounding clinical and demographic variables including lower education, higher unemployment, not being married or widowed, and history of abuse. After adjusting for these confounding variables, tobacco users continued to have greater pain intensity, a higher total and component FIQ scores except for fatigue. Smoking was not associated with a higher number of tender points. DISCUSSION: Current tobacco use was associated with more severe fibromyalgia symptoms in patients presenting to a specialized fibromyalgia treatment program.

Original languageEnglish (US)
Pages (from-to)39-43
Number of pages5
JournalClinical Journal of Pain
Volume25
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Fibromyalgia
Tobacco Use
Outpatients
Tobacco
Therapeutics
Pain
Demography
Medical Electronics
Widowhood
Confounding Factors (Epidemiology)
Unemployment
Electronic Health Records
Fatigue
Smoking
Surveys and Questionnaires
Databases
Education

Keywords

  • Fibromyalgia impact questionnaire
  • Fibromyalgia syndrome
  • Smoking

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology
  • Medicine(all)

Cite this

Weingarten, T. N., Podduturu, V. R., Hooten, W. M., Thompson, J. M., Luedtke, C. A., & Oh, T. H. (2009). Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia. Clinical Journal of Pain, 25(1), 39-43. https://doi.org/10.1097/AJP.0b013e31817d105e

Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia. / Weingarten, Toby N.; Podduturu, Vikram R.; Hooten, W. Michael; Thompson, Jeffrey M.; Luedtke, Connie A.; Oh, Terry H.

In: Clinical Journal of Pain, Vol. 25, No. 1, 01.2009, p. 39-43.

Research output: Contribution to journalArticle

Weingarten, Toby N. ; Podduturu, Vikram R. ; Hooten, W. Michael ; Thompson, Jeffrey M. ; Luedtke, Connie A. ; Oh, Terry H. / Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia. In: Clinical Journal of Pain. 2009 ; Vol. 25, No. 1. pp. 39-43.
@article{e43984a394204321aa27757fcb70f0e4,
title = "Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia",
abstract = "OBJECTIVES: This study examined the relationship between the severity of fibromyalgia symptoms and current tobacco use in patients evaluated at a specialized fibromyalgia treatment program. METHODS: Demographic and clinical data from 984 consecutive patients evaluated at the Mayo Clinic Fibromyalgia Treatment Program including the Fibromyalgia Impact Questionnaire (FIQ) were prospectively collected and stored in an electronic medical record and an electronic database. Univariate analyses were performed comparing tobacco users and nonusers. A post-hoc analysis of covariance was conducted for tobacco use, using group differences of confounding clinical and demographic variables. A P value ? 0.05 was accepted as the level of significance. RESULTS: One hundred and forty-five patients were identified as tobacco users (14.7{\%}). Tobacco use was associated with greater pain intensity as measured by pain scales and the pain component of the FIQ. Tobacco users had a greater FIQ composite score 70.0(15.1) versus 61.8(16.8), P<0.001. By univariate analysis, tobacco users had higher scores on all the FIQ components and fewer good days and more days of work missed per week. Tobacco use was associated with several confounding clinical and demographic variables including lower education, higher unemployment, not being married or widowed, and history of abuse. After adjusting for these confounding variables, tobacco users continued to have greater pain intensity, a higher total and component FIQ scores except for fatigue. Smoking was not associated with a higher number of tender points. DISCUSSION: Current tobacco use was associated with more severe fibromyalgia symptoms in patients presenting to a specialized fibromyalgia treatment program.",
keywords = "Fibromyalgia impact questionnaire, Fibromyalgia syndrome, Smoking",
author = "Weingarten, {Toby N.} and Podduturu, {Vikram R.} and Hooten, {W. Michael} and Thompson, {Jeffrey M.} and Luedtke, {Connie A.} and Oh, {Terry H.}",
year = "2009",
month = "1",
doi = "10.1097/AJP.0b013e31817d105e",
language = "English (US)",
volume = "25",
pages = "39--43",
journal = "Clinical Journal of Pain",
issn = "0749-8047",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgia

AU - Weingarten, Toby N.

AU - Podduturu, Vikram R.

AU - Hooten, W. Michael

AU - Thompson, Jeffrey M.

AU - Luedtke, Connie A.

AU - Oh, Terry H.

PY - 2009/1

Y1 - 2009/1

N2 - OBJECTIVES: This study examined the relationship between the severity of fibromyalgia symptoms and current tobacco use in patients evaluated at a specialized fibromyalgia treatment program. METHODS: Demographic and clinical data from 984 consecutive patients evaluated at the Mayo Clinic Fibromyalgia Treatment Program including the Fibromyalgia Impact Questionnaire (FIQ) were prospectively collected and stored in an electronic medical record and an electronic database. Univariate analyses were performed comparing tobacco users and nonusers. A post-hoc analysis of covariance was conducted for tobacco use, using group differences of confounding clinical and demographic variables. A P value ? 0.05 was accepted as the level of significance. RESULTS: One hundred and forty-five patients were identified as tobacco users (14.7%). Tobacco use was associated with greater pain intensity as measured by pain scales and the pain component of the FIQ. Tobacco users had a greater FIQ composite score 70.0(15.1) versus 61.8(16.8), P<0.001. By univariate analysis, tobacco users had higher scores on all the FIQ components and fewer good days and more days of work missed per week. Tobacco use was associated with several confounding clinical and demographic variables including lower education, higher unemployment, not being married or widowed, and history of abuse. After adjusting for these confounding variables, tobacco users continued to have greater pain intensity, a higher total and component FIQ scores except for fatigue. Smoking was not associated with a higher number of tender points. DISCUSSION: Current tobacco use was associated with more severe fibromyalgia symptoms in patients presenting to a specialized fibromyalgia treatment program.

AB - OBJECTIVES: This study examined the relationship between the severity of fibromyalgia symptoms and current tobacco use in patients evaluated at a specialized fibromyalgia treatment program. METHODS: Demographic and clinical data from 984 consecutive patients evaluated at the Mayo Clinic Fibromyalgia Treatment Program including the Fibromyalgia Impact Questionnaire (FIQ) were prospectively collected and stored in an electronic medical record and an electronic database. Univariate analyses were performed comparing tobacco users and nonusers. A post-hoc analysis of covariance was conducted for tobacco use, using group differences of confounding clinical and demographic variables. A P value ? 0.05 was accepted as the level of significance. RESULTS: One hundred and forty-five patients were identified as tobacco users (14.7%). Tobacco use was associated with greater pain intensity as measured by pain scales and the pain component of the FIQ. Tobacco users had a greater FIQ composite score 70.0(15.1) versus 61.8(16.8), P<0.001. By univariate analysis, tobacco users had higher scores on all the FIQ components and fewer good days and more days of work missed per week. Tobacco use was associated with several confounding clinical and demographic variables including lower education, higher unemployment, not being married or widowed, and history of abuse. After adjusting for these confounding variables, tobacco users continued to have greater pain intensity, a higher total and component FIQ scores except for fatigue. Smoking was not associated with a higher number of tender points. DISCUSSION: Current tobacco use was associated with more severe fibromyalgia symptoms in patients presenting to a specialized fibromyalgia treatment program.

KW - Fibromyalgia impact questionnaire

KW - Fibromyalgia syndrome

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=62349099159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62349099159&partnerID=8YFLogxK

U2 - 10.1097/AJP.0b013e31817d105e

DO - 10.1097/AJP.0b013e31817d105e

M3 - Article

C2 - 19158544

AN - SCOPUS:62349099159

VL - 25

SP - 39

EP - 43

JO - Clinical Journal of Pain

JF - Clinical Journal of Pain

SN - 0749-8047

IS - 1

ER -